The surge in coronavirus cases worldwide is helping researchers measure more quickly how well their vaccines protect against Covid-19.
Tag: Moderna Inc
Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
How to Ship a Vaccine at –80°C, and Other Obstacles in the Covid Fight
Developing an effective vaccine is the first step. Then comes the question of how to deliver hundreds of millions of doses that may need to be kept at arctic temperatures.
Moderna Coronavirus Vaccine Test in Monkeys Shows Promise
This coronavirus vaccine developed by government researchers and Moderna enabled the animals to quickly clear the infection from their lungs.
Moderna and Pfizer Begin Late-Stage Coronavirus Vaccine Trials
The studies each aim to enroll 30,000 people and determine whether the vaccines are safe and effective.
Oxford Covid Vaccine Among Those Developers Say Have Promising Initial Results
Early trials showed a good immune response in vaccinated subjects, but one researcher sounded a note of caution: “There is still a long way to go.”
Moderna Vaccine Trial: How Upbeat Coronavirus News Fueled a Stock Surge
The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs.
A New Entry in the Race for a Coronavirus Vaccine: Hope
Scientists are increasingly optimistic that a vaccine can be produced in record time. But getting it manufactured and distributed will pose huge challenges.
Moderna Gets OK to Start Larger Trial for a Coronavirus Vaccine
The company announced that the Food and Drug Administration had cleared its application to proceed to a clinical trial involving about 600 people.
More Coronavirus Vaccines and Treatments Move Toward Human Trials
Just three months after the start of the coronavirus pandemic, several biotech companies are beginning trials of promising vaccines and treatments.